Neither Tumor-Infiltrating Lymphocytes nor Cytotoxic T Cells Predict Enhanced Benefit from Chemotherapy in the DBCG77B Phase III Clinical Trial

SIMPLE SUMMARY: Apart from the direct killing of cancer cells, cyclophosphamide-based chemotherapy has been shown to induce an antitumor immune response, and is being used in combination with immunotherapies in cancer care. We assessed the interaction of chemotherapy with immune biomarkers expressed...

Descripción completa

Detalles Bibliográficos
Autores principales: Shenasa, Elahe, Stovgaard, Elisabeth Specht, Jensen, Maj-Britt, Asleh, Karama, Riaz, Nazia, Gao, Dongxia, Leung, Samuel, Ejlertsen, Bent, Laenkholm, Anne-Vibeke, Nielsen, Torsten O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367267/
https://www.ncbi.nlm.nih.gov/pubmed/35954471
http://dx.doi.org/10.3390/cancers14153808

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367267/
https://www.ncbi.nlm.nih.gov/pubmed/35954471
http://dx.doi.org/10.3390/cancers14153808

Ejemplares similares